Arax Advisory Partners’s GoHealth GOCO Stock Holding History

Arax Advisory Partners’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29	Closed	-$44	–	5229
2026 Q1	$44	Buy	+29	New	+$55	﹤0.01%	3668
2025 Q4	–	Sell	-198	Closed	-$954	–	4270
2025 Q3	$954	Buy	+198	New	+$1.08K	﹤0.01%	3266
2024 Q4	–	Sell	-103	Closed	-$967	–	2548
2024 Q3	$967	Hold	103	–	–	﹤0.01%	2273
2024 Q2	$1K	Buy	+103	New	+$1.02K	﹤0.01%	2173

Other funds holding GOCO

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return

NEWAS

N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return

GBT

Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arax Advisory Partners's GOCO Position: Q2 2026 in Review

Arax Advisory Partners sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 29 shares — an estimated $44 sold.

Arax Advisory Partners first reported a position in GOCO in Q2 2024 and held it in 4 quarters. The position peaked at $1K in Q2 2024. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

Arax Advisory Partners reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
Arax Advisory Partners sold 29 GoHealth shares in Q2 2026, an estimated $44.
Arax Advisory Partners first reported a position in GoHealth in Q2 2024 and held it in 4 quarters.
Arax Advisory Partners's GoHealth position peaked at $1K in Q2 2024.
5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.